Sethi JM, (2000) Smoking and chronic obstructive pulmonary disease, Clin Chest Med

Barnes PJ, (1999) Genetics and pulmonary medicine. 9. Molecular genetics of chronic obstructive pulmonary disease, Thorax

Silverman EK, (1998) Genetic epidemiology of severe, early-onset chronic obstructive pulmonary disease: risk to relatives for airflow obstruction and chronic bronchitis, Am J Respir Crit Care Med

Sandford AJ, (2000) Genetic risk factors for chronic obstructive pulmonary disease, Clin Chest Med

Hersh CP, (2005) Chapter 10. Chronic obstructive pulmonary disease. In Respiratory genetics, Edward Arnold Publishers

Travis J, (1983) Human plasma proteinase inhibitors, Annu Rev Biochem

Brantly ML, (1988) Clinical features and history of the destructive lung disease associated with alpha-1-antitrypsin deficiency of adults with pulmonary symptoms, Am Rev Respir Dis

Crystal RG, (1990) α1-antitrypsin deficiency, emphysema and liver disease: genetic basis and strategies for therapy, J Clin Invest

Fagerhol MK, (1970) The Pi system-inherited variants of serum alpha 1-antitrypsin, Prog Med Genet

Mittman C, (1973) Alpha 1-antitrypsin deficiency as an indicator of susceptibility to pulmonary disease, J Occup Med

(1997) α1-antitrypsin deficiency: memorandum from a WHO meeting, Bull World Health Organ

Crystal RG, (1989) The α1-antitrypsin gene and its mutations: clinical consequences and strategies for therapy, Chest

Gaillard MC, (1992) Alpha-1-protease inhibitor in bronchial asthma: phenotypes and biochemical characteristics, Am Rev Respir Dis

Gaillard MC, (1994) Ethnic differences in the occurrence of the M1(ala213) haplotype of alpha-1-antitrypsin in asthmatic and non-asthmatic black and white South Africans, Clin Genet

Rieger S, (1999) Multiplex PCR assay for the detection of genetic variants of α1-antitrypsin, Clin Chem

Pauwels RA, (2001) Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary, Am J Respir Crit Care Med

Lucotte G, (1999) Polymerase chain reaction detection of S and Z alpha-1-antitrypsin variants by duplex PCR assay, Mol Cell Probes

Park JY, (2001) Prevalence of α1-antitrypsin genotypes in Koreans, Tuber Respir Dis

Silverman EK, (1996) Risk factors for the development of chronic obstructive pulmonary disease, Med Clin North Am

Silverman EK, (2002) Genomewide linkage analysis of quantitative spirometric phenotypes in severe early-onset chronic obstructive pulmonary disease, Am J Hum Genet

Vineis P, (1997) Molecular epidemiology: low-dose carcinogens and genetic susceptibility, Int J Cancer

Nakachi K, (1991) Genetic susceptibility to squamous cell carcinoma of the lung in relation to cigarette smoking dose, Cancer Res

Xu LL, (2001) The NAD(P)H:quinone oxidoreductase 1 gene polymorphism and lung cancer: differential susceptibility based on smoking behavior, Cancer Epidemiol Biomarkers Prev

Billingsley GD, (1993) Physical mapping of four serpin genes: alpha 1-antitrypsin, alpha 1-antichymotrypsin, corticosteroid-binding globulin, and protein C inhibitor, within a 280-kb region on chromosome 14q32.1, Am J Hum Genet

Rollini P, (1997) A 370-kb cosmid contig of the serpin gene cluster on human chromosome 14q32.1: molecular linkage of the genes encoding alpha 1-antichymotrypsin, protein C inhibitor, kallistatin, alpha 1-antitrypsin, and corticosteroid-binding globulin, Genomics

Lieberman J, (1986) Alpha 1-antitrypsin Pi-types in 965 COPD patients, Chest